Abstract:A comprehensive phytochemical study of Juniperus turbinata (Cupressaceae) collected from La Maddalena Archipelago (Sardinia, Italy) is reported. Both the essential oil and the ethanolic extract obtained from the aerial parts were analyzed. The essential oil appears to belong to a new chemotype compared to other Mediterranean juniper accessions, as it was favored by geographic isolation of the isles. It showed a low content of monoterpene hydrocarbons and α-terpineol, ent-manoyl oxide, 1,10-di-epi-cubenol as th… Show more
“…In some cases the chemotaxonomic relevance has also been demonstrated. In gymnosperms, apigenin derivatives are mostly present in dimeric forms, with apigenin residues variously coupled, e.g., with C‒C linkage as in cupressuflavone and amentoflavone (I-8, II-8″ and I-3′, II-8″, respectively), or C‒O linkage (I-4′, II-6″) as in hinokiflavone (Figure 2) [24,25,26,27]. Biogenetically, apigenin is a product of the phenylpropanoid pathway and may be obtained from both phenylalanine and tyrosine, two shikimate-derived precursors.…”
Several plant bioactive compounds have exhibited functional activities that suggest they could play a remarkable role in preventing a wide range of chronic diseases. The largest group of naturally-occurring polyphenols are the flavonoids, including apigenin. The present work is an updated overview of apigenin, focusing on its health-promoting effects/therapeutic functions and, in particular, results of in vivo research. In addition to an introduction to its chemistry, nutraceutical features have also been described. The main key findings from in vivo research, including animal models and human studies, are summarized. The beneficial indications are reported and discussed in detail, including effects in diabetes, amnesia and Alzheimer’s disease, depression and insomnia, cancer, etc. Finally, data on flavonoids from the main public databases are gathered to highlight the apigenin’s key role in dietary assessment and in the evaluation of a formulated diet, to determine exposure and to investigate its health effects in vivo.
“…In some cases the chemotaxonomic relevance has also been demonstrated. In gymnosperms, apigenin derivatives are mostly present in dimeric forms, with apigenin residues variously coupled, e.g., with C‒C linkage as in cupressuflavone and amentoflavone (I-8, II-8″ and I-3′, II-8″, respectively), or C‒O linkage (I-4′, II-6″) as in hinokiflavone (Figure 2) [24,25,26,27]. Biogenetically, apigenin is a product of the phenylpropanoid pathway and may be obtained from both phenylalanine and tyrosine, two shikimate-derived precursors.…”
Several plant bioactive compounds have exhibited functional activities that suggest they could play a remarkable role in preventing a wide range of chronic diseases. The largest group of naturally-occurring polyphenols are the flavonoids, including apigenin. The present work is an updated overview of apigenin, focusing on its health-promoting effects/therapeutic functions and, in particular, results of in vivo research. In addition to an introduction to its chemistry, nutraceutical features have also been described. The main key findings from in vivo research, including animal models and human studies, are summarized. The beneficial indications are reported and discussed in detail, including effects in diabetes, amnesia and Alzheimer’s disease, depression and insomnia, cancer, etc. Finally, data on flavonoids from the main public databases are gathered to highlight the apigenin’s key role in dietary assessment and in the evaluation of a formulated diet, to determine exposure and to investigate its health effects in vivo.
“…Juniperus turbinata Guss.) ethanol extract showed the strongest cytotoxic activity (IC 50 values of 0.06, 0.114, and 0.201 μM on human colon cancer HCT116, human malignant melanoma A375, and human breast adenocarcinoma MDA-MB-231 cell lines, respectively), being several times more potent than the reference compound cisplatin (IC 50 values of 1.87 to 11.86 μM) [ 19 ] indicating that imbricataloic acid make a promising anticancer drug candidate.…”
Section: Introductionmentioning
confidence: 99%
“…Juniperus turbinata Guss.) exhibits cytotoxic effects against HCT116, A375, and MDA-MB-231 human tumor cell lines, in a concentration-dependent inhibitory effect with IC 50 values of 9.48–33.69 μg/mL [ 19 ]. Juniperus oxycedrus essential oil exhibited high antitrypanosomal activity (IC 50 of 0.9 μg/mL) against Trypanosoma brucei brucei , with no cytotoxic effects on RAW 267.4 macrophage cell line showing the highest selectivity index (63.4) [ 20 ].…”
Background: Plants and their derived natural compounds possess various biological and therapeutic properties, which turns them into an increasing topic of interest and research. Juniperus genus is diverse in species, with several traditional medicines reported, and rich in natural compounds with potential for development of new drugs. Methods: The research for this review were based in the Scopus and Web of Science databases using terms combining Juniperus, secondary metabolites names, and biological activities. This is not an exhaustive review of Juniperus compounds with biological activities, but rather a critical selection taking into account the following criteria: (i) studies involving the most recent methodologies for quantitative evaluation of biological activities; and (ii) the compounds with the highest number of studies published in the last four years. Results: From Juniperus species, several diterpenes, flavonoids, and one lignan were emphasized taking into account their level of activity against several targets. Antitumor activity is by far the most studied, being followed by antibacterial and antiviral activities. Deoxypodophyllotoxin and one dehydroabietic acid derivative appears to be the most promising lead compounds. Conclusions: This review demonstrates the Juniperus species value as a source of secondary metabolites with relevant pharmaceutical potential.
“…Cupressoflavone ( 1 ) was previously reported from Juniperus turbinate (Venditti et al, ), and it was shown to possess cytotoxic activity against the human cancer cell lines breast adenocarcinoma (MDA‐MB 231), malignant melanoma (A375), and colon carcinoma (HCT116), with IC 50 values of 16.1, 12.7, and 19.3 μM, respectively, after 72 hr incubation using the MTT assay. However, on the present study, compound 1 displayed a significant decrease in the percentage viability of lung cancer cells A549 at concentrations higher than 0.33 μM (Table ).…”
Three biflavonoids [cupressuflavone (1), amentoflavone (2), and sumaflavone (3)], four diterpenoids [13-epi-cupressic acid (4), imbricatholic acid (5), 3-hydroxysandaracopimaric acid (6), and dehydroabietic acid (7)], and one lignan [β-peltatin methyl ether (8)] were isolated from the cytotoxic fractions of the extracts of the leaves of the Libyan Juniperus phoenicea L. The structures of these compounds were elucidated by spectroscopic means. Cytotoxicity of compounds 1-6 were assessed against the human lung cancer cell line A549 using the MTT assay. Compounds 1 and 3 showed cytotoxicity against the A549 cells (IC 50 = 65 and 77 μM, respectively), whereas compound 2 did not show any activity. Diterpenes 4-6 exhibited weak cytotoxicity against the A549 cells with the IC 50 values of 159, 263, and 223 μM, respectively. The cytotoxicity of each compound was compared with the anticancer drug, etoposide (IC 50 = 61 μM). Cupressuflavone (1) was evaluated also for cytotoxicity against both the human PC3 cancer cell line and the normal prostate cell line (PNT2), and this compound revealed a high degree of cytotoxic selectivity towards the prostate cancer cells (PC3), with IC 50 value of 19.9 μM, without any evidence of cytotoxicity towards the normal prostate cell line (PNT2).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.